Etoposide

Form: Oral Capsules & Injection:

Strength: Injection: 20 mg/mL; Capsule: 50 mg

Reference Brands: US: Toposar® (injection) VePesid® (capsules); EU: Etopophos® (injectable phosphate form) Vepesid® (capsules)

Category: Oncology Cancer Care

Etoposide is a potent oncology agent available in the US and EU, widely used to treat small cell lung cancer, testicular cancer, and various hematologic malignancies. Available as 20 mg/mL injection and 50 mg oral capsules, Etoposide disrupts DNA replication by inhibiting topoisomerase II, leading to cancer cell death. Sold under brand names like Toposar®, VePesid®, and Etopophos®, and as numerous generics, it remains a cornerstone in combination chemotherapy protocols. Etoposide is a trusted and essential option in hospital procurement and pharmaceutical B2B supply chains across regulated markets.